AGIOS PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Charges
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Increase (Decrease) in Deferred Charges of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2021-02-25
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in deferred charges for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in deferred charges for the quarter ending 2019-09-30 was $0.00.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in deferred charges for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in deferred charges for the quarter ending 2019-03-31 was $0.00.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in deferred charges for fiscal 2020 was $0.00.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in deferred charges for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in deferred charges for fiscal 2018 was $82.00K, a 97.00% decline from fiscal 2017.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in deferred charges for fiscal 2017 was $2.73M.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | $138.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | $138.00K derived: sum of 3 quarters · filed 2021-02-25 | $66.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-02 | $138.00K derived: sum of 2 quarters · filed 2021-02-25 | $66.00K derived: sum of 3 quarters · filed 2021-02-25 | $178.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $66.00K derived: sum of 2 quarters · filed 2021-02-25 | $178.00K derived: sum of 3 quarters · filed 2021-02-25 | $82.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $40.00K derived: sum of 2 quarters · filed 2019-10-31 | -$56.00K 10-Q · filed 2019-10-31 | $154.00K derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $16.00K 10-Q · filed 2019-08-01 | $226.00K derived: sum of 3 quarters · filed 2020-02-19 | $1.09M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | -$96.00K 10-Q · filed 2019-05-02 | $114.00K derived: sum of 2 quarters · filed 2020-02-19 | $980.00K derived: sum of 3 quarters · filed 2020-02-19 | $1.83M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $1.08M derived: sum of 2 quarters · filed 2020-02-19 | $1.93M derived: sum of 3 quarters · filed 2020-02-19 | $2.73M 10-K · filed 2020-02-19 |
| 2017-09-30 | $866.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.72M derived: sum of 2 quarters · filed 2018-11-01 | $2.52M 10-Q · filed 2018-11-01 | $3.34M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $852.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.65M 10-Q · filed 2018-08-02 | $2.47M derived: sum of 3 quarters · filed 2019-02-14 | $1.12M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $801.00K 10-Q · filed 2018-05-04 | $1.62M derived: sum of 2 quarters · filed 2019-02-14 | $268.00K derived: sum of 3 quarters · filed 2019-02-14 | -$1.10M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $820.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | -$533.00K derived: sum of 2 quarters · filed 2019-02-14 | -$1.91M derived: sum of 3 quarters · filed 2019-02-14 | -$1.35M 10-K · filed 2019-02-14 |
| 2016-09-30 | -$1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$2.73M derived: sum of 2 quarters · filed 2017-11-01 | -$2.17M 10-Q · filed 2017-11-01 | -$2.42M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-06-30 | -$1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$813.00K 10-Q · filed 2017-08-08 | -$1.07M derived: sum of 3 quarters · filed 2018-02-14 | -$2.93M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-03-31 | $560.00K 10-Q · filed 2017-05-04 | $304.00K derived: sum of 2 quarters · filed 2018-02-14 | -$1.56M derived: sum of 3 quarters · filed 2018-02-14 | -$7.03M derived: sum of 4 quarters · filed 2018-02-14 |
| 2015-12-31 | -$256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | -$2.12M derived: sum of 2 quarters · filed 2018-02-14 | -$7.59M derived: sum of 3 quarters · filed 2018-02-14 | -$15.80M 10-K · filed 2018-02-14 |
| 2015-09-30 | -$1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$7.33M derived: sum of 2 quarters · filed 2016-11-03 | -$15.55M 10-Q · filed 2016-11-03 | -$19.16M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-30 | -$5.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$13.69M 10-Q · filed 2016-08-08 | -$17.30M derived: sum of 3 quarters · filed 2017-02-16 | -$17.43M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-31 | -$8.22M 10-Q · filed 2016-05-09 | -$11.83M derived: sum of 2 quarters · filed 2017-02-16 | -$11.96M derived: sum of 3 quarters · filed 2017-02-16 | -$11.93M derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | -$3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | -$3.75M derived: sum of 2 quarters · filed 2017-02-16 | -$3.71M derived: sum of 3 quarters · filed 2017-02-16 | -$3.69M 10-K · filed 2017-02-16 |
| 2014-09-30 | -$135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$104.00K derived: sum of 2 quarters · filed 2015-11-06 | -$80.00K 10-Q · filed 2015-11-06 | |
| 2014-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $55.00K 10-Q · filed 2015-08-07 | ||
| 2014-03-31 | $24.00K 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $85.00K 10-K · filed 2016-02-26 | |||
| 2012-12-31 | $46.00K 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |